BVT Aktienanleihe MRK 31.12.2024/ DE000VD1TP38 /
2024-05-03 7:42:19 PM | Chg.+0.520 | Bid9:58:03 PM | Ask9:58:03 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
98.030EUR | +0.53% | - Bid Size: - |
- Ask Size: - |
MERCK KGAA O.N. | 150.00 EUR | 2024-12-31 | Call |
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA